-Thomas R Spitzer Researcher Activity Profile

Research Author Detailed Information 

Thomas R Spitzer Publication Rate By Year

Thomas R Spitzer has published 1 paper(s) in 2005, 6 paper(s) in 2007, 5 paper(s) in 2008, for a total of 12 research publications in total.

Thomas R Tr Spitzer Author Information

LAST NAME: spitzer

FIRST NAME: Thomas R

INITIALS: tr

AFFILIATION:

Papers

Thomas R Spitzer's Publication Record

1. Haploidentical stem cell transplantation: the always present but overlooked donor. Year Published: 2005
2. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Year Published: 2007
Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. kballen@partners.org
3. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Year Published: 2007
Hematology/Oncology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. kballen@partners.org <kballen@partners.org>
4. Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Year Published: 2007
Transplantation Biology Research Center, Bone Marrow Transplantation Section, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129, USA.
5. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Year Published: 2007
Bone Marrow Transplant Program, Massachusetts General Hospital, 0 Emerson Place, Suite 118, 55 Fruit Street, Boston, MA 02114, USA.
6. Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors. Year Published: 2008
1Hematology/Oncology Unit, Division of Bone Marrow Transplantation, Massachusetts General Hospital, Boston, MA, USA.
7. Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors. Year Published: 2008
1Hematology/Oncology Unit, Division of Bone Marrow Transplantation, Massachusetts General Hospital, Boston, MA, USA.
8. Current status of reduced-intensity allogeneic stem cell transplantation using alternative donors. Year Published: 2008
Hematology/Oncology Unit, Division of Bone Marrow Transplantation, Massachusetts General Hospital, Boston, MA 02114, USA.
9. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Year Published: 2007
Bone Marrow Transplant Program, Massachusetts General Hospital, 0 Emerson Place, Suite 118, 55 Fruit Street, Boston, MA 02114, USA.
10. HLA-mismatched renal transplantation without maintenance immunosuppression. Year Published: 2008
Transplantation Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, USA.
11. HLA-mismatched renal transplantation without maintenance immunosuppression. Year Published: 2008
Transplantation Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, USA.
12. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Year Published: 2007
Hematology/Oncology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. kballen@partners.org <kballen@partners.org>